Update on Humain Ventures' early investments, discussion of space-based biotech research vs. product ownership, and how product-focused platforms attract pharma capital despite current VC cycles.
Transcript
chevron_right
Play full episode
chevron_right
Transcript
Episode notes
Dr. Aneil Mallavarapu is leading Humain Ventures, an early stage venture capital firm focused on TechBio. We recorded a conversation together live in San Francisco with an all star audience of friends. At the intersection of biology and AI, there’s something game changing going on and TechBio aims to capture this. Aneil and his partner, 23andMe co-founder Linea Avey are both early pioneers in TechBio so learning from them is a real treat.
Thanks a ton to Brady Forrest from Ignite for hosting this event.
